{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,7,20]],"date-time":"2025-07-20T03:56:41Z","timestamp":1752983801207,"version":"3.37.3"},"reference-count":41,"publisher":"Oxford University Press (OUP)","issue":"6","license":[{"start":{"date-parts":[[2021,11,26]],"date-time":"2021-11-26T00:00:00Z","timestamp":1637884800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/100010269","name":"Wellcome Trust","doi-asserted-by":"publisher","award":["104079\/Z\/14\/Z"],"award-info":[{"award-number":["104079\/Z\/14\/Z"]}],"id":[{"id":"10.13039\/100010269","id-type":"DOI","asserted-by":"publisher"}]},{"name":"UCB-Oxford University Alliance, BMA Research Grants- Vera Down"},{"DOI":"10.13039\/501100000295","name":"Epilepsy Research UK","doi-asserted-by":"publisher","award":["P1201"],"award-info":[{"award-number":["P1201"]}],"id":[{"id":"10.13039\/501100000295","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100013373","name":"NIHR Oxford Biomedical Research Centre","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100013373","id-type":"DOI","asserted-by":"publisher"}]},{"name":"NHS"},{"DOI":"10.13039\/100006662","name":"NIHR","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100006662","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100018754","name":"Department of Health","doi-asserted-by":"publisher","award":["WO\/210\/046716"],"award-info":[{"award-number":["WO\/210\/046716"]}],"id":[{"id":"10.13039\/100018754","id-type":"DOI","asserted-by":"publisher"}]},{"name":"Hungarian Brain Research Program","award":["20017-1.2.1-NKP-2017-00002","EFOP-3.6.2-16-2017-00008"],"award-info":[{"award-number":["20017-1.2.1-NKP-2017-00002","EFOP-3.6.2-16-2017-00008"]}]}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2022,5,30]]},"abstract":"<jats:title>Abstract<\/jats:title>\n               <jats:sec>\n                  <jats:title>Background<\/jats:title>\n                  <jats:p>Fibromyalgia syndrome (FMS) is the most common chronic widespread pain condition in rheumatology. Until recently, no clear pathophysiological mechanism for fibromyalgia had been established, resulting in management challenges. Recent research has indicated that serum immunoglobulin Gs (IgGs) may play a role in FMS. We undertook a research prioritisation exercise to identify the most pertinent research approaches that may lead to clinically implementable outputs.<\/jats:p>\n               <\/jats:sec>\n               <jats:sec>\n                  <jats:title>Methods<\/jats:title>\n                  <jats:p>Research priority setting was conducted in five phases: situation analysis; design; expert group consultation; interim recommendations; consultation and revision. A dialogue model was used, and an international multi-stakeholder expert group was invited. Clinical, patient, industry, funder, and scientific expertise was represented throughout. Recommendation-consensus was determined via a voluntary closed eSurvey. Reporting guideline for priority setting of health research were employed to support implementation and maximise impact.<\/jats:p>\n               <\/jats:sec>\n               <jats:sec>\n                  <jats:title>Results<\/jats:title>\n                  <jats:p>Arising from the expert group consultation (n\u2009=\u200929 participants), 39 interim recommendations were defined. A response rate of 81.5% was achieved in the consensus survey. Six recommendations were identified as high priority- and 15 as medium level priority. The recommendations range from aspects of fibromyalgia features that should be considered in future autoantibody research, to specific immunological investigations, suggestions for trial design in FMS, and therapeutic interventions that should be assessed in trials.<\/jats:p>\n               <\/jats:sec>\n               <jats:sec>\n                  <jats:title>Conclusions<\/jats:title>\n                  <jats:p>By applying the principles of strategic priority setting we directed research towards that which is implementable, thereby expediating the benefit to the FMS patient population. These recommendations are intended for patients, international professionals and grant-giving bodies concerned with research into causes and management of patients with fibromyalgia syndrome.<\/jats:p>\n               <\/jats:sec>","DOI":"10.1093\/pm\/pnab338","type":"journal-article","created":{"date-parts":[[2021,11,24]],"date-time":"2021-11-24T20:20:54Z","timestamp":1637785254000},"page":"1084-1094","source":"Crossref","is-referenced-by-count":6,"title":["Research Recommendations Following the Discovery of Pain Sensitizing IgG Autoantibodies in Fibromyalgia Syndrome"],"prefix":"10.1093","volume":"23","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-3763-8206","authenticated-orcid":false,"given":"Andreas","family":"Goebel","sequence":"first","affiliation":[{"name":"Institute of Life Course and Medicine Sciences, Pain Research Institute, University of Liverpool, and Walton Centre NHS Foundation Trust , Liverpool, UK"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"David","family":"Andersson","sequence":"additional","affiliation":[{"name":"Institute of Psychiatry, Psychology and Neuroscience, Wolfson Centre for Age Related Disease, King\u2019s College , London, UK"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Chris","family":"Barker","sequence":"additional","affiliation":[{"name":"Lancashire and South Cumbria NHS Foundation Trust , UK"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Neil","family":"Basu","sequence":"additional","affiliation":[{"name":"Institute of Infection, Immunity & Inflammation, University of Glasgow , Glasgow, UK"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Craig","family":"Bullock","sequence":"additional","affiliation":[{"name":"Versus Arthritis, Copeman House, St Mary\u2019s Court, St Mary\u2019s Gate , Chesterfield, UK"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Stuart","family":"Bevan","sequence":"additional","affiliation":[{"name":"Institute of Psychiatry, Psychology and Neuroscience, Wolfson Centre for Age Related Disease, King\u2019s College , London, UK"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Rachael J M","family":"Bashford-Rogers","sequence":"additional","affiliation":[{"name":"Wellcome Centre for Human Genetics , Oxford, UK"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-4459-8609","authenticated-orcid":false,"given":"Ernest","family":"Choy","sequence":"additional","affiliation":[{"name":"CREATE Centre, Division of Infection and Immunity, Cardiff University , UK"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"David","family":"Clauw","sequence":"additional","affiliation":[{"name":"Anesthesiology, Medicine (Rheumatology) and Psychiatry University of Michigan , Ann Arbor, Michigan, USA"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Debra","family":"Dulake","sequence":"additional","affiliation":[{"name":"Patient Representative, Relative , Mansfield, UK"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Richard","family":"Dulake","sequence":"additional","affiliation":[{"name":"Patient Representative, Relative , Mansfield, UK"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Herta","family":"Flor","sequence":"additional","affiliation":[{"name":"Institute of Cognitive and Clinical Neuroscience, Central Institute of Mental Health, Medical Faculty Mannheim, Heidelberg University , Mannheim, Germany"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Marcia","family":"Glanvill","sequence":"additional","affiliation":[{"name":"Patient Representative , Liverpool, UK"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Zsuzsanna","family":"Helyes","sequence":"additional","affiliation":[{"name":"Department of Pharmacology and Pharmacotherapy, Medical School & Szent\u00e1gothai Research Centre, University of P\u00e9cs , P\u00e9cs, Hungary"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-7667-9748","authenticated-orcid":false,"given":"Sarosh","family":"Irani","sequence":"additional","affiliation":[{"name":"Oxford Autoimmune Neurology Group, John Radcliffe Hospital, University of Oxford , Oxford, UK"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Eva","family":"Kosek","sequence":"additional","affiliation":[{"name":"Department of Clinical Neuroscience, Karolinska Institutet , Stockholm, Sweden"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jennifer","family":"Laird","sequence":"additional","affiliation":[{"name":"Eli Lilly and Company, Pain & Neurodegeneration Therapeutic Area, Lilly Research Centre , Windlesham, Surrey, UK"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Gary","family":"MacFarlane","sequence":"additional","affiliation":[{"name":"Epidemiology Group , Aberdeen, Scotland"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-2322-3314","authenticated-orcid":false,"given":"Hayley","family":"McCullough","sequence":"additional","affiliation":[{"name":"Institute of Life Course and Medicine Sciences, Pain Research Institute, University of Liverpool , Liverpool, UK"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Andrew","family":"Marshall","sequence":"additional","affiliation":[{"name":"Institute of Life Course and Medicine Sciences, Pain Research Institute, University of Liverpool, and Walton Centre NHS Foundation Trust , Liverpool, UK"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Robert","family":"Moots","sequence":"additional","affiliation":[{"name":"Faculty of Health Social Care and Medicine, Edge Hill University , Liverpool, UK"},{"name":"Liverpool University Hospitals NHS Foundation Trust , Liverpool, UK"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Serge","family":"Perrot","sequence":"additional","affiliation":[{"name":"Pain Center, Cochin Hospital, Paris University , Paris, France"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-9852-5811","authenticated-orcid":false,"given":"Nick","family":"Shenker","sequence":"additional","affiliation":[{"name":"Rheumatology Research Unit, Addenbrooke\u2019s Hospital , Cambridge, UK"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Emanuele","family":"Sher","sequence":"additional","affiliation":[{"name":"Eli Lilly and Company, Pain & Neurodegeneration Therapeutic Area, Lilly Research Centre , Windlesham, Surrey, UK"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Claudia","family":"Sommer","sequence":"additional","affiliation":[{"name":"Department of Neurology, University Hospital W\u00fcrzburg , Germany"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Camilla I","family":"Svensson","sequence":"additional","affiliation":[{"name":"Department of Physiology and Pharmacology, Center for Molecular Medicine, Karolinska Institutet , Stockholm, Sweden"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-3761-8704","authenticated-orcid":false,"given":"Amanda","family":"Williams","sequence":"additional","affiliation":[{"name":"Health Psychology, UCL Research Department of Clinical, Educational & Health Psychology, University College London , UK"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Geoff","family":"Wood","sequence":"additional","affiliation":[{"name":"Cambridge Institute for Medical Research , Cambridge, UK"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Emma R","family":"Dorris","sequence":"additional","affiliation":[{"name":"School of Medicine, University College Dublin , Ireland"}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"286","published-online":{"date-parts":[[2021,11,26]]},"reference":[{"issue":"1","key":"2022060107570191300_pnab338-B1","doi-asserted-by":"crossref","first-page":"28","DOI":"10.1097\/j.pain.0000000000001390","article-title":"The IASP classification of chronic pain for ICD-11: Chronic primary pain","volume":"160","author":"Nicholas","year":"2019","journal-title":"Pain"},{"issue":"5","key":"2022060107570191300_pnab338-B2","doi-asserted-by":"crossref","first-page":"ITC33","DOI":"10.7326\/AITC202003030","article-title":"Fibromyalgia","volume":"172","author":"Bair","year":"2020","journal-title":"Ann Intern Med"},{"key":"2022060107570191300_pnab338-B3","first-page":"617","article-title":"2016 modified American College of Rheumatology fibromyalgia criteria, ACTTION-APS Pain Taxonomy criteria and the prevalence of fibromyalgia","author":"Hauser","year":"2020","journal-title":"Arthritis Care Res"},{"issue":"2","key":"2022060107570191300_pnab338-B4","doi-asserted-by":"crossref","first-page":"318","DOI":"10.1136\/annrheumdis-2016-209724","article-title":"EULAR revised recommendations for the management of fibromyalgia","volume":"76","author":"Macfarlane","year":"2017","journal-title":"Ann Rheum Dis"},{"author":"Goebel","key":"2022060107570191300_pnab338-B5"},{"issue":"1","key":"2022060107570191300_pnab338-B6","doi-asserted-by":"crossref","first-page":"243","DOI":"10.1186\/s12874-019-0889-3","article-title":"Reporting guideline for priority setting of health research (REPRISE)","volume":"19","author":"Tong","year":"2019","journal-title":"BMC Med Res Methodol"},{"issue":"3","key":"2022060107570191300_pnab338-B7","doi-asserted-by":"crossref","first-page":"e34","DOI":"10.2196\/jmir.6.3.e34","article-title":"Improving the quality of Web surveys: The Checklist for Reporting Results of Internet E-Surveys (CHERRIES)","volume":"6","author":"Eysenbach","year":"2004","journal-title":"J Med Internet Res"},{"key":"2022060107570191300_pnab338-B8","doi-asserted-by":"crossref","first-page":"37","DOI":"10.9774\/GLEAF.4700.2002.su.00006","article-title":"Towards a managerial practice of stakeholder engagement: Developing multi-stakeholder learning dialogues","volume":"6","author":"Payne","year":"2002","journal-title":"J Corporate Citizenship"},{"issue":"6","key":"2022060107570191300_pnab338-B9","doi-asserted-by":"crossref","first-page":"661","DOI":"10.1002\/jca.21662","article-title":"Patient consultation about a trial of therapeutic plasma exchange for complex regional pain syndrome","volume":"33","author":"Goebel","year":"2018","journal-title":"J Clin Apher"},{"key":"2022060107570191300_pnab338-B10","volume-title":"Complex Regional Pain Syndrome in Adults","author":"Goebel","year":"2018","edition":"2nd edition"},{"issue":"3","key":"2022060107570191300_pnab338-B11","first-page":"35","article-title":"Patient phenotypes in fibromyalgia comorbid with systemic sclerosis or rheumatoid arthritis: Influence of diagnostic and screening tests. Screening with the FiRST questionnaire, diagnosis with the ACR 1990 and revised ACR 2010 criteria","volume":"35 Suppl 105","author":"Perrot","year":"2017","journal-title":"Clin Exp Rheumatol"},{"issue":"3","key":"2022060107570191300_pnab338-B12","doi-asserted-by":"crossref","first-page":"319","DOI":"10.1016\/j.semarthrit.2016.08.012","article-title":"2016 Revisions to the 2010\/2011 fibromyalgia diagnostic criteria","volume":"46","author":"Wolfe","year":"2016","journal-title":"Semin Arthritis Rheum"},{"issue":"5","key":"2022060107570191300_pnab338-B13","doi-asserted-by":"crossref","first-page":"532","DOI":"10.1097\/ACO.0b013e32834a1091","article-title":"Fibromyalgia: A primer for the anesthesia community","volume":"24","author":"Brummett","year":"2011","journal-title":"Curr Opin Anaesthesiol"},{"issue":"9 Suppl","key":"2022060107570191300_pnab338-B14","doi-asserted-by":"crossref","first-page":"T93","DOI":"10.1016\/j.jpain.2016.06.002","article-title":"Overlapping chronic pain conditions: Implications for diagnosis and classification","volume":"17","author":"Maixner","year":"2016","journal-title":"J Pain"},{"issue":"3","key":"2022060107570191300_pnab338-B15","doi-asserted-by":"crossref","first-page":"553","DOI":"10.1002\/ana.25173","article-title":"N-methyl-D-aspartate receptor antibody production from germinal center reactions: Therapeutic implications","volume":"83","author":"Makuch","year":"2018","journal-title":"Ann Neurol"},{"issue":"2","key":"2022060107570191300_pnab338-B16","doi-asserted-by":"crossref","first-page":"329","DOI":"10.1016\/j.rdc.2009.05.002","article-title":"Key symptom domains to be assessed in fibromyalgia (outcome measures in rheumatoid arthritis clinical trials)","volume":"35","author":"Choy","year":"2009","journal-title":"Rheum Dis Clin North Am"},{"issue":"4","key":"2022060107570191300_pnab338-B17","doi-asserted-by":"crossref","first-page":"707","DOI":"10.1515\/sjpain-2019-0142","article-title":"Exploring the impact of pain management programme attendance on complex regional pain syndrome (CRPS) patients' decision making regarding immunosuppressant treatment to manage their chronic pain condition","volume":"20","author":"Murray","year":"2020","journal-title":"S and J Pain"},{"issue":"7","key":"2022060107570191300_pnab338-B18","doi-asserted-by":"crossref","first-page":"835","DOI":"10.1016\/j.jpain.2017.02.434","article-title":"Lower placebo responses after long-term exposure to fibromyalgia pain","volume":"18","author":"Kosek","year":"2017","journal-title":"J Pain"},{"issue":"3","key":"2022060107570191300_pnab338-B19","first-page":"149","article-title":"Guidelines on the use of therapeutic apheresis in clinical practice-evidence-based approach from the Writing Committee of the American Society for Apheresis: The Seventh Special Issue","volume":"31","author":"Schwartz","year":"2016","journal-title":"J Clin Apher"},{"issue":"4","key":"2022060107570191300_pnab338-B20","doi-asserted-by":"crossref","first-page":"504","DOI":"10.1002\/ana.25565","article-title":"Reduction of skin innervation is associated with a severe fibromyalgia phenotype","volume":"86","author":"Evdokimov","year":"2019","journal-title":"Ann Neurol"},{"issue":"2","key":"2022060107570191300_pnab338-B21","doi-asserted-by":"crossref","first-page":"196","DOI":"10.1002\/ana.24065","article-title":"Hyperexcitable C nociceptors in fibromyalgia","volume":"75","author":"Serra","year":"2014","journal-title":"Ann Neurol"},{"issue":"4","key":"2022060107570191300_pnab338-B22","doi-asserted-by":"crossref","first-page":"806","DOI":"10.1016\/j.neuron.2018.01.033","article-title":"Immune or genetic-mediated disruption of CASPR2 causes pain hypersensitivity due to enhanced primary afferent excitability","volume":"97","author":"Dawes","year":"2018","journal-title":"Neuron"},{"issue":"5","key":"2022060107570191300_pnab338-B23","doi-asserted-by":"crossref","first-page":"924","DOI":"10.1093\/rheumatology\/kep458","article-title":"Fibromyalgic rheumatoid arthritis and disease assessment","volume":"49","author":"Pollard","year":"2010","journal-title":"Rheumatology (Oxford)"},{"issue":"5","key":"2022060107570191300_pnab338-B24","doi-asserted-by":"crossref","first-page":"1386","DOI":"10.1002\/art.39051","article-title":"Characteristics of fibromyalgia independently predict poorer long-term analgesic outcomes following total knee and hip arthroplasty","volume":"67","author":"Brummett","year":"2015","journal-title":"Arthritis Rheumatol"},{"issue":"6","key":"2022060107570191300_pnab338-B25","doi-asserted-by":"crossref","first-page":"1434","DOI":"10.1097\/ALN.0b013e3182a8eb1f","article-title":"Survey criteria for fibromyalgia independently predict increased postoperative opioid consumption after lower-extremity joint arthroplasty: A prospective, observational cohort study","volume":"119","author":"Brummett","year":"2013","journal-title":"Anesthesiology"},{"issue":"5","key":"2022060107570191300_pnab338-B26","doi-asserted-by":"crossref","first-page":"1103","DOI":"10.1097\/ALN.0000000000000637","article-title":"Fibromyalgia survey criteria are associated with increased postoperative opioid consumption in women undergoing hysterectomy","volume":"122","author":"Janda","year":"2015","journal-title":"Anesthesiology"},{"volume-title":"Patients Who Fail Biologics Are More Likely to Have Concomitant Fibromyalgia. ACR\/ARHP; 2014","year":"2014","author":"Katz","key":"2022060107570191300_pnab338-B27"},{"issue":"1","key":"2022060107570191300_pnab338-B28","doi-asserted-by":"crossref","first-page":"58","DOI":"10.3899\/jrheum.080366","article-title":"Rheumatoid arthritis and fibromyalgia: A frequent unrelated association complicating disease management","volume":"36","author":"Coury","year":"2009","journal-title":"J Rheumatol"},{"issue":"2","key":"2022060107570191300_pnab338-B29","doi-asserted-by":"crossref","first-page":"119","DOI":"10.1046\/j.1526-4637.2002.02018.x","article-title":"Human pooled immunoglobulin in the treatment of chronic pain syndromes","volume":"3","author":"Goebel","year":"2002","journal-title":"Pain Med"},{"issue":"7","key":"2022060107570191300_pnab338-B30","doi-asserted-by":"crossref","first-page":"1072","DOI":"10.1111\/pme.12319","article-title":"Immunoglobulin G for the treatment of chronic pain: Report of an expert workshop","volume":"15","author":"Tamburin","year":"2014","journal-title":"Pain Med"},{"issue":"2","key":"2022060107570191300_pnab338-B31","doi-asserted-by":"crossref","first-page":"208","DOI":"10.1093\/rheumatology\/kem345","article-title":"A subset of fibromyalgia patients have findings suggestive of chronic inflammatory demyelinating polyneuropathy and appear to respond to IVIg","volume":"47","author":"Caro","year":"2007","journal-title":"Rheumatology (Oxford)"},{"issue":"4","key":"2022060107570191300_pnab338-B32","doi-asserted-by":"crossref","first-page":"308","DOI":"10.3109\/03009749709105321","article-title":"Dermal IgG deposits and increase of mast cells in patients with fibromyalgia: Relevant findings or epiphenomena?","volume":"26","author":"Enestrom","year":"1997","journal-title":"Scand J Rheumatol"},{"issue":"26","key":"2022060107570191300_pnab338-B33","doi-asserted-by":"crossref","first-page":"13067","DOI":"10.1073\/pnas.1820168116","article-title":"Transfer of complex regional pain syndrome to mice via human autoantibodies is mediated by interleukin-1-induced mechanisms","volume":"116","author":"Helyes","year":"2019","journal-title":"Proc Natl Acad Sci USA"},{"issue":"4","key":"2022060107570191300_pnab338-B34","doi-asserted-by":"crossref","first-page":"730","DOI":"10.1136\/annrheumdis-2015-208094","article-title":"Autoantibodies to citrullinated proteins induce joint pain independent of inflammation via a chemokine-dependent mechanism","volume":"75","author":"Wigerblad","year":"2016","journal-title":"Ann Rheum Dis"},{"issue":"11","key":"2022060107570191300_pnab338-B35","doi-asserted-by":"crossref","first-page":"1982","DOI":"10.1093\/rheumatology\/key206","article-title":"Influence of co-morbid fibromyalgia on disease activity measures and response to tumour necrosis factor inhibitors in axial spondyloarthritis: Results from a UK national register","volume":"57","author":"Macfarlane","year":"2018","journal-title":"Rheumatology (Oxford)"},{"issue":"10","key":"2022060107570191300_pnab338-B36","doi-asserted-by":"crossref","first-page":"1911","DOI":"10.1185\/030079906X132488","article-title":"painDETECT: A new screening questionnaire to identify neuropathic components in patients with back pain","volume":"22","author":"Freynhagen","year":"2006","journal-title":"Curr Med Res Opin"},{"issue":"2","key":"2022060107570191300_pnab338-B37","doi-asserted-by":"crossref","first-page":"250","DOI":"10.1016\/j.pain.2010.03.034","article-title":"Development and validation of the Fibromyalgia Rapid Screening Tool (FiRST)","volume":"150","author":"Perrot","year":"2010","journal-title":"Pain"},{"issue":"1","key":"2022060107570191300_pnab338-B38","doi-asserted-by":"crossref","first-page":"28","DOI":"10.1111\/j.1752-4571.2007.00006.x","article-title":"The great opportunity: Evolutionary applications to medicine and public health","volume":"1","author":"Nesse","year":"2008","journal-title":"Evol Appl"},{"volume-title":"Good Reasons for Bad Feelings: Insights from the Frontier of Evolutionary Psychiatry","year":"2019","author":"Nesse","key":"2022060107570191300_pnab338-B39"},{"issue":"1","key":"2022060107570191300_pnab338-B40","doi-asserted-by":"crossref","first-page":"19","DOI":"10.1155\/2013\/742510","article-title":"Patients' and professionals' views on managing fibromyalgia","volume":"18","author":"Briones-Vozmediano","year":"2013","journal-title":"Pain Res Manag"},{"issue":"4","key":"2022060107570191300_pnab338-B41","doi-asserted-by":"crossref","first-page":"671","DOI":"10.3899\/jrheum.081180","article-title":"Fibromyalgia wars","volume":"36","author":"Wolfe","year":"2009","journal-title":"J Rheumatol"}],"container-title":["Pain Medicine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/academic.oup.com\/painmedicine\/advance-article-pdf\/doi\/10.1093\/pm\/pnab338\/41823918\/pnab338.pdf","content-type":"application\/pdf","content-version":"am","intended-application":"syndication"},{"URL":"https:\/\/academic.oup.com\/painmedicine\/article-pdf\/23\/6\/1084\/43891871\/pnab338.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"syndication"},{"URL":"https:\/\/academic.oup.com\/painmedicine\/article-pdf\/23\/6\/1084\/43891871\/pnab338.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,6,1]],"date-time":"2022-06-01T08:00:13Z","timestamp":1654070413000},"score":1,"resource":{"primary":{"URL":"https:\/\/academic.oup.com\/painmedicine\/article\/23\/6\/1084\/6443164"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,11,26]]},"references-count":41,"journal-issue":{"issue":"6","published-online":{"date-parts":[[2021,11,26]]},"published-print":{"date-parts":[[2022,5,30]]}},"URL":"https:\/\/doi.org\/10.1093\/pm\/pnab338","relation":{},"ISSN":["1526-2375","1526-4637"],"issn-type":[{"type":"print","value":"1526-2375"},{"type":"electronic","value":"1526-4637"}],"subject":[],"published-other":{"date-parts":[[2022,6,1]]},"published":{"date-parts":[[2021,11,26]]}}}